Hindustan Bio Sciences Ltd (532041) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532041 | NSE: | Pharmaceuticals & Drugs | Small Cap

Hind Bio Science Share Price

5.97 0.27 4.74%
as on 05-Dec'25 12:16

Hindustan Bio Sciences Ltd (532041) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532041 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Hind Bio Science

Based on:

M-Cap below 100cr DeciZen not available

Hindustan Bio Sciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
278.24
Market Cap:
5.8 Cr.
52-wk low:
5.7
52-wk high:
11.7

Is Hindustan Bio Sciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Hind Bio Science: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hindustan Bio Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -30.2%-8.4%-49%2.7%2.4%-23.7%-16.7%-1.1%1.7%2.9%-
Value Creation
Index
-3.2-1.6-4.5-0.8-0.8-2.7-2.2-1.1-0.9-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1.3113.61.910.40.91.10.81
Sales YoY Gr.--19.8%2%245.6%-45.5%-46.9%-58.3%114%14.1%-22.9%-
Adj EPS -0.7-0.5-2.20.10.1-0.9-0.5-00.10.10
YoY Gr.-NANANA-27.3%-1237.5%NANANA66.7%-
BVPS (₹) 4.74.222.12.21.30.80.70.80.90.8
Adj Net
Profit
-0.7-0.5-2.30.10.1-0.9-0.5-00.10.10
Cash Flow from Ops. 0.5-0.2-0.2-1.30.80.8-0.3-0.1-1.40-
Debt/CF from Ops. 2.1-8-6.9-2.63.22.5-6.3-49.3-1.892.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -4.8%-16%23.5%-22.9%
Adj EPS NA4.6%NA66.7%
BVPS-17%-16.7%4.6%12.8%
Share Price 5% 13.4% 13.7% -46.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-12.7-10.7-71.35.33.7-52.6-49.2-5.37.4122.3
Op. Profit
Mgn %
-9.8-46-227.93.87-90.3-116.4-3.16.112.613.9
Net Profit
Mgn %
-58.9-48.6-220.73.14.2-90.5-119.4-4.45.512.62.9
Debt to
Equity
0.20.30.81.61.21.42.83.33.22.83
Working Cap
Days
1,6732,0691,6534591,0011,5432,6881,2191,1341,49960
Cash Conv.
Cycle
931199910525613221310214019859

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Hindustan Bio Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0.7 -
BVPS (₹.) 0.8 -
Reserves (₹ Cr.) -1 -
P/BV 6.80 -
PE 278.24 -
From the Market
52 Week Low / High (₹) 5.70 / 11.73
All Time Low / High (₹) 0.10 / 106.65
Market Cap (₹ Cr.) 5.8
Equity (₹ Cr.) 2.1
Face Value (₹) 2
Industry PE 40.7

Management X-Ray of Hind Bio Science:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Hind Bio Science - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Hind Bio Science

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1.261.011.033.561.941.030.430.921.050.81
Operating Expenses 1.381.483.383.431.811.970.940.950.990.71
Manufacturing Costs0.030.050.040.030.020.010.01000
Material Costs0.860.730.572.891.300.680.240.570.640.49
Employee Cost 0.220.210.160.160.200.190.180.180.090.07
Other Costs 0.280.492.610.350.291.090.510.200.260.15
Operating Profit -0.12-0.47-2.350.130.14-0.94-0.51-0.030.060.10
Operating Profit Margin (%) -9.8%-46.0%-227.0%3.7%7.0%-91.1%-117.0%-3.1%6.1%12.3%
Other Income 000.090000000
Interest 0.030.0100.010.010.010000
Depreciation 0.010.010.010.010.010.0100.010.010
Exceptional Items -1.92000000000
Profit Before Tax -2.08-0.49-2.270.110.12-0.96-0.51-0.040.050.10
Tax 00000.04-0.0200-0-0
Profit After Tax -2.09-0.49-2.280.110.08-0.94-0.52-0.040.060.10
PAT Margin (%) -165.0%-48.5%-220.0%3.1%4.2%-91.1%-120.0%-4.4%5.5%12.4%
Adjusted EPS (₹)-2.0-0.5-2.20.10.1-0.9-0.5-0.00.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 4.824.332.052.162.241.300.790.750.800.90
Share Capital 10.2510.2510.2510.2510.2510.2510.252.052.052.05
Reserves -5.43-5.92-8.20-8.09-8.01-8.95-9.46-1.30-1.25-1.15
Minority Interest0000000000
Debt0.941.301.573.372.601.862.172.462.562.51
Long Term Debt0.360.550.762.471.670.731.071.122.562.51
Short Term Debt0.580.750.810.890.931.131.091.3300
Trade Payables0.090.210.070.060.660.2900.0600
Others Liabilities -0.01-0-0.010.010.040.020.020.0200
Total Liabilities 5.845.843.685.605.553.482.973.283.373.41

Fixed Assets

Gross Block0.530.530.540.540.540.540.550.550.550.55
Accumulated Depreciation0.460.470.480.480.490.500.510.510.520.52
Net Fixed Assets 0.070.060.060.060.050.040.040.030.030.03
CWIP 0000000000
Investments 0000000000
Inventories000.080.110.3400000
Trade Receivables0.470.470.321.671.360.620.140.450.440.44
Cash Equivalents 0.030.040.020.180.200.020.010.010.040.01
Others Assets 5.275.273.213.573.602.802.792.792.862.93
Total Assets 5.845.843.685.605.553.482.973.283.373.41

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.46-0.16-0.23-1.320.820.75-0.34-0.05-1.410.03
PBT -0.16-0.49-2.270.110.12-0.96-0.51-0.040.050.10
Adjustment 0.040.020.010.010.010.040.230.010.010
Changes in Working Capital 0.580.312.03-1.450.711.65-0.06-0.02-1.47-0.07
Tax Paid 0000-0.020.020000
Cash Flow From Investing Activity -0-0-0-0.0100-0000
Capex -0-0-0-0.0100-0000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -0.630.180.211.50-0.81-0.930.340.051.43-0.05
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -0.600.190.221.50-0.81-0.930.340.051.43-0.05
Interest Paid -0.02-0.01-0-0000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow -0.170.01-0.020.170.01-0.18-0.0100.03-0.02

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-35.6-10.74-71.35.223.67-52.96-49.49-5.287.4311.78
ROCE (%)-30.17-8.37-49.032.682.4-23.7-16.66-1.11.742.94
Asset Turnover Ratio0.180.170.220.770.350.230.130.30.320.24
PAT to CFO Conversion(x)N/AN/AN/A-1210.25N/AN/AN/A-23.50.3
Working Capital Days
Receivable Days115170139102285350319116155198
Inventory Days13028104300000
Payable Days507689810225522521191

Hindustan Bio Sciences Ltd Stock News

Hindustan Bio Sciences Ltd FAQs

The current trading price of Hind Bio Science on 05-Dec-2025 12:16 is ₹5.97.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Hind Bio Science stood at ₹5.84.
The latest P/E ratio of Hind Bio Science as of 04-Dec-2025 is 278.2.
The latest P/B ratio of Hind Bio Science as of 04-Dec-2025 is 6.80.
The 52-week high of Hind Bio Science is ₹11.73 and the 52-week low is ₹5.70.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hind Bio Science is ₹0.70 ( Cr.) .

About Hindustan Bio Sciences Ltd

Hindustan Bio Sciences was incorporated in 1991. It is a limited company with a share capital of U.S $2.5 million based in Hyderabad, India. The people at the helm of affairs of the company are associated with pharmaceutical and healthcare sector for over two decades and are having penetrative knowledge of the needs of the sick. Hindustan Biosciences is a new entrant in the field of biopharmaceutical industry for providing quality healthcare for the treatment of life threatening diseases at affordable cost even to the lower income segment of Indian Society.

The company started its activities in the year 2001 and has been identifying potential recombinant DNA based biopharmaceutical products for marketing in India. The company has outsourced the manufacturing activity presently and the owned manufacturing facilities will be established at a latter stage. At present the company is setting up a research and development facility for developing the R DNA based biopharmaceuticals for human consumption. The company has finalized a technical consultation tie-up with CCMB (Centre for Cellular and Molecular Biology).

Products

The company has obtained the approval of Genetic Engineering Approval Committee (GEAC) for import and marketing of Recombinant Human Erythropoietin manufactured by M/s. Shandong Kexing Bioproducts Co., Shandong, China. The protocol submitted by the company to conduct clinical trials has been approved by DCGI (Drug Controller General of India) and ethics committees of concerned Hospitals.

Hindustan Bio Sciences, engages in the import and marketing of recombinant deoxyribonucleic acid products for the treatment of life threatening diseases in India. It markets human erythropoietin manufactured by Shandong Kexing Bioproducts Co.

In 2001 the company entered into an agreement with CDSL, NSDL and Venture Capital & Corporate Investments Ltd (R&T agents) for dematerialization. In 2004 Hindustan Bio bagged GEAC nod recombinant human erythropoietin.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×